As of Apr 20
| +0.04 / +1.82%|
The 1 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +123.21% increase from the last price of 2.24.
The current consensus among 4 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.